The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries
<p>Abstract</p> <p>Background</p> <p>Despite the increase in the number of clinical trials in low and middle income countries (LMICs), there has been little serious discussion of whether First in Human (FIH; phase 0 and phase 1) clinical trials should be conducted in LM...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-10-01
|
| Series: | BMC Public Health |
| Online Access: | http://www.biomedcentral.com/1471-2458/11/811 |